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Abstract
BACKGROUND: Type II diabetes mellitus (TIIDM) has been associated with structural and functional changes in 
the brain. TIIDM is commonly associated with obesity, insulin resistance, hypertension, and dyslipidemia, all of which 
can have negative impact on brain.
AIM: The aim of the study was to study the risk of mild cognitive impairment (MCI) among both diabetics and non-
diabetics and to identify risk factors to MCI among both groups.
METHODS: Two comparative cross-sectional studies were carried out enrolling 100 diabetics and 100 age, sex, and 
education matching non-diabetics. Cognitive function was assessed using Montreal Cognitive Assessment (MoCA) 
test and risk factors for MCI were assessed.
RESULTS: The subjective complaint of memory impairment among diabetics was significantly higher (34%) compared 
to non-diabetics (13.0%), p < 0.05. The mean of objective MoCA score was significantly lower among diabetics 
(25.9 ± 2.5) compared to non-diabetics (27.4 ± 2.4), p < 0.001. The rate of MCI was significantly higher among TIIDM 
patients (22%) compared to non-diabetics (9%), p < 0.01 and odds ratio (OR) 2.8 (95% confidence interval 1.2–6.5). 
Among the two studied groups, the rate of MCI was significantly higher among those aged over 50 years compared 
to younger age as well as among hypertensive compared to non-hypertensive persons, (p < 0.05). Among diabetics, 
the MCI was significantly higher among those with secondary education, having heart diseases, longer duration of 
DM, or repeated hypoglycemia attack, p < 0.05. A healthy diet, brain training, and social activities were found to be 
significantly associated with normal cognition. Logistic analysis revealed that diabetics aged above 50 was the only 
significant predicting factor for MCI with an OR 2.9 (95% CI: 3.8–123.3), p < 0.001.
CONCLUSION: TIIDM is significantly associated with 3-times increasing risk of having MCI compared to non-
diabetics. The age, hypertension, cardiovascular diseases, duration of diabetes, and frequency of hypoglycemic 
episodes are risk factors for cognitive impairment. A healthy diet, brain training, and social activities were associated 
with better cognitive function.
Introduction
Cognition is a collective word for a range of 
higher brain functions containing language, memory, 
reasoning, and perception. Mild cognitive impairment 
(MCI) is an intermediate state between normal ageing 
and dementia including Alzheimer’s disease (AD). MCI 
is a syndrome characteristic of early stages of many 
neurodegenerative diseases [1], [2]. Cognitive decline 
and dementia are among the most feared and most 
common illnesses of old age, making the identification 
of changeable risk factors for them, a crucial public 
health importance [3]. Diabetic patients may be 
susceptible to develop mental health problems because 
diabetes is counted as one of the most behaviorally and 
psychologically serious chronic medical illnesses [4].
The worldwide number of diabetic patients 
is expected to increase from 171 million in 2000 to 
366 million by 2030. The prevalence was highest in the 
Eastern Mediterranean Region increasing from 5.9% 
(6 million) in 1980 to 13.7% (43 million) in 2014. The 
prevalence of diabetes in adults in Middle East and 
North Africa in 2019, 2030, and 2045 is 12.2%, 13.3%, 
and 13.9%, respectively. Regarding diabetes-related 
deaths, 43% occurred before the age of 70, with the 
highest proportion occurring in low- and middle-income 
countries [5], [6]. The International Diabetes Federation 
listed Egypt among the world top ten countries in the 
number of diabetic patients. It is alarming that the 
DM prevalence in Egypt has increased quickly within 
a short period from approximately 4.4 million in 2007 
to 8.9 million in 2019 and it is expected to jump to 
11.9 million by 2030 and 16.9 million by 2045 [6], [7].
The risk of cognitive dysfunction in Type II 
diabetes mellitus (TIIDM) may be affected by 
glycemic control, inflammation, hypoglycemia, macro/
microvascular pathology, and depression. The 
increasing effect of these conditions on the vascular 
etiology may decrease the threshold of cognition 
affection by other neurological conditions in the aging 
brain [8].
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For diabetic patients, managerial functions are 
particularly important as when patients are asked to do 
complex tasks such as matching treatment dose with 
carbohydrate content, expecting the effect of physical 
activity on blood glucose, or identifying, and treating 
hypoglycemia correctly [9].
The aim of the study is to detect MCI among 
both diabetics and non-diabetics and to identify risk 
factors related to MCI among both groups.
Subjects and Methods
The study is a comparative cross-sectional 
study. It was done at Zagazig University outpatient 
clinics, Sharkya Governorate. These clinics serve 
the city and most of the nearby villages. Method for 
sampling of TIIDM patients was a convenient non 
probability sampling, where all TIIDM patients attended 
to the clinic during the period of study were selected 
from the medical records. It included 100 TIIDM patients 
with an age which ranges from 40 to 60 years old. The 
second group composed of 100 non-diabetic subjects 
with age, sex, and education matched to the diabetic 
group. They were patients attending the outpatient 
clinics with mild symptoms (not serious health problem 
such as abdominal cramps, cough, viral infections, and 
mild fever) and their fasting blood sugar was below 
100 mg/dL. Written consent was obtained from all 
participants after ensuring their full understanding of 
the research. The approval of head of diabetes unit 
at Zagazig University Hospitals before starting the 
research was taken.
A questionnaire was designed and pilot 
study was done before implementation. A face to face 
interview was carried out with studied participants 
to fulfill the questionnaire. It was used to collect data 
on general demographics (age, sex, and education), 
smoking habit (smoking or not), and medical history 
(memory complaints and its effect on his job and 
social life, cardiovascular problems, hypertension, and 
family history of dementia). Diabetic history of TIIDM 
patients (duration of diabetes, regular treatment or 
not, and hypoglycemic episodes) was also assessed. 
Dietary habits were also assessed in the questionnaire 
regarding (fast food, balanced main meal, canned 
tuna, eggs, beans, vegetables, fruits, unroasted nuts, 
dark chocolate, and dairy products). Social activities 
(going to clubs and mosques), intellectual activities 
(reading, listening to the radio, using the internet, and 
playing mental games), and physical activities were 
also assessed in the questionnaire. Anthropometric 
measurements (weight and length) and waist/hip ratio, 
and systolic and diastolic blood pressure were assessed.
The case definition of MCI was based on 
the recommendations of the National Institute on 
Aging–Alzheimer’s Association [10], depending on 
subjective complaint, objective detection using cognitive 
test, and normal daily activities using 36 short form 
quality of life. Subjective Concern regarding a change 
in cognition: There should be evidence of concern 
about a change in cognition, in comparison with the 
person’s previous level. We measured subjective 
cognitive concerns through two questions according 
to Lara et al. (2016): “How would you best describe 
your memory at present?,” with answer options being 
very good, good, moderate, bad or very bad, and 
“Compared to 12 months ago, would you say your 
memory is now better, the same or worse than it was 
then?” Participants were considered to have memory 
complaints if they answered “bad” or “very bad” to the 
former question and/or “worse” to the latter [11].
Objective impairment in one or more cognitive 
domains: The current study is planned to detect MCI 
among both diabetics and non-diabetics, using the 
Arabic version of the Montreal Cognitive Assessment 
(MoCA) test after having permission for use. It assesses 
visuospatial abilities using a clock-drawing task and 
a three-dimensional cube copy. Short-term memory 
recall that contains two learning trials of five nouns and 
delayed recall after approximately 5 min is assessed. 
Attention, concentration, and working memory are 
evaluated using a sustained attention task, a serial 
subtraction task, and digits forward and backwards. 
Orientation to time and place is evaluated. Multiple 
aspects of executive functions are assessed using an 
alternation task adapted from the trail making B task, a 
phonemic fluency task, and a two-item verbal abstraction 
task. Finally, language is assessed using a three-item 
confrontation naming task with low-familiarity animals, 
repetition of two syntactically complex sentences, 
and the aforementioned fluency task [12], [13]. The 
maximum score is 30 points, any score greater than or 
equal to 26 points indicates a normal cognition. It has 
high sensitivity (90%) and specificity (87%) for detecting 
individuals with MCI [13], [14].
Data management and analysis
The collected data were revised, coded, 
entered, and verified with proofreading data, where 
one researcher checked the data entered against 
the original document. Data analysis was done 
using Statistical Package for the Social Sciences 
18 for windows. Qualitative data were presented in 
frequencies and percentages. Chi-squared test was 
used for measuring differences meanwhile odds ratio 
(OR) and 95% confidence interval (CI) were computed 
to assess the degree of association. Mean, standard 
deviation, and t-test were used for quantitative data, 
when comparing between two means. When data are 
not normally distributed, non-parametric Mann–Whitney 
test was used. Multivariate logistic analysis was done 
to predict risk factors significantly associated with MCI. 
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p < 0.05 was considered significant and p < 0.01 was 
considered highly significant.
Results
The mean age among diabetic group was 50.7 
± 6.6 years and 56% of them were females and 85% 
were married. While the mean age among non-diabetics 
was 50.4 ± 6.4 years and 59% of them were females 
and 90% were married. The education level in the two 
groups was more or less comparable and around half of 
both groups had university education level. About 40% 
of the both groups had professional jobs.
Table 1 presents subjective complaint of 
memory impairment among all participants. The 
percentages of diabetics complained of frequent 
forgetfulness, bad/good memory, those who family and 
friends complained from their memory or complained 
that their memory affected their daily work were 
significantly higher compared to non-diabetic group 
(p < 0.05).
Depending on subjective complaint, objective 
cognitive impairment and normal daily activities, 22 
diabetics were suffered from MCI (22%) compared to 
nine non-diabetics individuals (9%), p = 0.01 and OR 
2.8 (95 % CI 1.2–6.5). The mean MoCA score test was 
significantly lower among diabetics or non-diabetics 
with MCI (23.2 ± 1.3 and 23.6 ± 1.3, respectively) 
compared to those with normal cognition in both groups 
(26.8 ± 2.2 and 27.7 ± 2.1, respectively), p<0.001.
Table 3 presents the socio-demographic, 
medical, and physical history among diabetics and 
non-diabetics in relation to MCI. Among diabetics, the 
prevalence of MCI was significantly higher among 
those aged >50, those with secondary education, 
hypertensive patients, those with heart diseases, having 
longer duration of DM, or repeated hypoglycemia, 
p<0.05. Among non-diabetics, the prevalence of MCI 
was significantly higher among those aged >50 and 
hypertensive patients, p<0.05.
The mean monthly intake of fast food, dairy 
products, eggs, and nuts was significantly lower among 
diabetics with MCI than among those with normal 
cognition, p < 0.05. The mean monthly intake of fast food, 
balanced main meal, eggs, canned tuna, and unroasted 
nuts was significantly lower among non-diabetics with 
MCI compared to those with normal cognition (p < 0.05). 
Diabetics with normal cognition had higher monthly 
social activities than those with MCI, p < 0.05. While, 
non-diabetics with normal cognition spent more hours in 
praying at mosques and playing mental games compared 
to those with MCI, (p < 0.001) (Table 4).
Logistic regression analysis for predicting the 
risk of MCI among diabetics was carried out using 
age, sex, education, smoking, body mass index (BMI), 
hypertension, heart disease, regular treatment, and 
history of hypoglycemia in the model. It revealed that 
diabetics aged above 50 and those with hypertension 
were the only significant predicting factors for MCI, 
p < 0.01 (Table 5).
Discussion
With the growing interest in MCI, our study 
discussed two major observations: The first, the 
prevalence of MCI among both diabetics and non-
diabetics, and second, risk factors for MCI among both 
groups.
The prevalence of diabetes and MCI is 
increasing worldwide partially due to the increase 
in the aging population and lifestyle choices [15]. In 
this study, the prevalence of MCI was 22% among 
the diabetic group and 9% among the non-diabetic 
group with almost 3 times increased risk of having 
Table 2 shows that the mean of total MoCA 
score was significantly lower among diabetics than non-
diabetics (p < 0.001). The means of certain domains 
as verbal fluency, abstraction, and delayed recall also 
showed significant difference between both groups, 
(p < 0.05).
Table 1: Subjective complaint of memory impairment among 
all participants
Variables Diabetics n=100
n (%)
Non-diabetics n=100 
n (%)
p-value
Complaint of frequent forgetfulness 
Yes 34 (34.0) 13 (13.0) <0.001**
No 66 (66.0) 87 (87.0)
Describe your memory 
Excellent/very good 38 (38.0) 65 (65.0) <0.001**
Good 53 (53.0) 32 (32.0)
Bad 9 (9.00) 3 (3.00)
Memory compared to previous year
Same 82 (82.0) 82 (82.0) 1.00
Worse 18 (18.0) 18 (18.0)
Family and friends complain from your memory
Yes 21 (21.0) 1 (1.00) <0.001**
No 79 (79.0) 99 (99.0)
Does your memory affect your ability to do your daily work
Yes 8 (8.00) 0 (0.00) 0.04*
No 92 (92.0) 100 (100.0)
*p<0.05, **p<0.001.
Table 2: MoCA test cognitive domains and total score among 
studied participants
Variables Diabetics n=100
Mean±SD
Non-diabetics n=100
Mean±SD
p-value
Visuospatial 4.0±0.9 4.1±0.9 0.650
Naming (animal) 2.8±0.4 2.9±0.3 0.149
Attention 5.4±0.7 5.4±0.8 0.163
Language 2.0±0.2 2.0±0.3 0.762
Verbal fluency 0.5±0.5 0.9±0.2 <0.0005**
Abstraction 1.7±0.8 2.0±0.1 <0.0005**
Delayed recall 3.8±1.0 5.8±0.5 0.041*
Orientation 5.7±0.5 5.8±0.5 0.406
Total MoCA score 25.9±2.5 27.4±2.4 <0.0005**
*p<0.05, **p<0.001. SD: Standard deviation, MoCA: Montreal cognitive assessment.
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MCI, p < 0.01 and the mean of total MoCA score was 
significantly lower among diabetics than non-diabetics 
(p < 0.001) and this was also reported by Li et al. 
(2019) using the MoCA, (p < 0.05) [16]. Several studies 
showed that the prevalence of MCI among studied 
Type II diabetic patients was higher than among non-
diabetics [16], [17], [18]. Other studies as Salama et al. 
(2018) in Cairo and Ding et al. (2015) in China found 
that the prevalence of MCI was 14.2% and 20.1%, 
respectively, among healthy individuals [19], [20]. The 
variation in the prevalence of MCI has been due to the 
demographic characteristics of the source populations, 
implementation of MCI diagnostic criteria, differences 
in sampling procedures, the education level, and the 
age range of participants (especially the studies done in 
Cairo and Mansoura had age range ≥ 60 years and the 
dementia of normal aging may have played a role in this 
prevalence).
The present study aimed to find the risk factors 
for MCI among both diabetics and non-diabetics. In 
accordance to other studies [21], [22], and [23], the 
prevalence of MCI among both groups increased 
significantly with age with p < 0.01 and by making a 
logistic regression analysis, old age (above 50) was a 
significant predicting factor for MCI among diabetics, 
p < 0.001. In the current study, the prevalence of MCI 
Table 3: Relation between socio-demographic, medical, and physical history among diabetics and non-diabetics in relation to MCI
Variables Total n=100 MCI among diabetics Total n=100 MCI among non-diabetics
MCI n=22 Odds ratio (CI 95%) MCI n=9 Odds ratio (CI 95%)
Age in years
≤50 47 1 (2.1) ® 52 0 (0.0) Undefined OR
>50 53 21 (39.6) 30.2 (3.9–235.9)** 48 9 (100.0) p<0.01
Gender
Males 44 12 (27.3) 1.7 (0.6–4.47) 42 1 (2.4) 6.5 (0.8–54.6)
Females 56 10 (17.9) ® 58 8 (13.8) ®
Education
Secondary 18 10 (55.6) 7.3 (2.4–22.2)** 23 4 (17.4) 3.0 (0.7–12.4)
University and postgraduation 82 12 (14.6) ® 77 5 (6.5) ®
Smoking
Current or previous smoker 28 9 (32.1) 2.1 (0.8–5.8) 21 4 (19.0) 3.4 (0.8–14.4)
Non-smoker 72 13 (18.1) ® 79 5 (6.3) ®
Obesity
Non-obese (BMI <30) 70 16 (21.3) ® 64 7 (10.9) ®
obese (BMI ≥30) 30 6 (24.0) 1.2 (0.4–3.4) 36 2 (5.6) 2.1 (0.4–10.6)
Light physical activity
Yes 39 5 (12.8) ® 29 1 (3.4) ®
No 61 17 (27.0) 2.6 (0.9–7.8) 71 8 (11.3) 3.5 (0.4–29.8)
History of family dementia
Yes 32 7 (21.9) 0.9 (0.4–2.7) 57 4 (7.0) 1.7 (0.4–6.9)
No 68 15 (22.1) ® 43 5 (11.6) ®
Hypertension
Yes 69 19 (27.5) 3.5 (0.9–13.1)* 29 6 (20.6) 8.3 (1.6–42.5)*
No 31 3 (9.7) ® 71 3 (4.2) ®
Heart diseases
Yes 16 7 (43.8) 3.5 (1.2–11.1)* 16 2 (12.5) 1.6 (0.3–8.4)
No 84 15 (17.9) ® 84 7 (8.3) ®
Duration of diabetes - - -
More than 10 years 61 19 (31.1) 5.4 (1.4–19.8)*
<10 years 39 3 (7.7) ®
Regular treatment - - -
Irregular 10 3 (30.0) 1.6 (0.4–6.7)
Regular 90 19 (21.1) ®
History of Hypoglycemia - - -
Yes 14 8 (57.1) 4.6 (1.4–15.1)*
No 86 16 (18.6) ®
*p<0.05, **p<0.001. MCI: Mild cognitive impairment, CI: Confidence interval, ®: Reference group, OR: Odds ratio, BMI: Body mass index.
Table 5: Logistic regression analysis for predicting the risk of 
MCI among diabetics
Variables B p OR 95%CI of OR
Lower Upper
Age 0.400 <0.001 1.492 1.229 1.811
Hypertension 1.805 <0.01 6.078 1.054 35.040
B: Regression coefficient, OR: Odds ratio, CI: Confidence interval. Variables entered in the model: age, 
sex, education, smoking, BMI, hypertension, heart disease, regular treatment and history of hypoglycemia.
Table 4: Dietary and social risk factors among diabetics and non-diabetics in relation to MCI
Variables Cognitive function among diabetics Cognitive function among non-diabetics
MCI 
n=22 Mean±SD
Normal
n=78 Mean±SD
p-value MCI
n=9 Mean±SD
Normal
n=78 Mean±SD
p-value
Dietary risk factors
Fast food 5.09±6.89 8.9±5.6 0.022* 2.2±2.1 7.8±5.7 <0.0005**
Balanced main meal 17.6±4.39 15.8±4.7 0.113 15.3±4.3 18.6±3.4 0.023*
Canned tuna 1.27±2.27 1.07±2.0 0.695 1.3±2.2 3.5±1.3 0.005*
Eggs 3.45±5.2 9.4±5.5 <0.001** 3.1±3.8 8.8±4.7 0.01*
Beans 5.4±7.2 6.6±6.4 0.514 5.7±4.05 7.3±7.1 0.308
Vegetables 16±4.27 15.1±3.9 0.404 16±2.8 14.7±3.6 0.308
Fruits 19.1±6.4 18.5±6.3 0.706 18.6±3.4 18.1±5.17 0.657
Unroasted nuts 0.7±2.0 3.4±4.2 <0.001** 0.4±1.3 3.5±4.2 0.032*
Dark chocolate 0.36±1.7 0.4±1.5 0.902 0.0±0.0 0.3±1.07 0.074
Dairy products 15.2±5.6 18.5±5.6 0.022* 19.5±3.7 19.2±4.6 0.849
Social risk factors
Going to clubs 0.5±1.87 2.5±4.2 0.031* 0.4±1.3 1.4±3.1 0.343
Mosques 2±2.04 1.7±2.38 0.982 0.0±0.0 2.02±2.8 <0.001**
Reading 17.7±19.4 15.9±23.3 0.747 23.3±20.0 20.27±29.6 0.763
Listening to radio 30±33.3 51.1±41.05 0.01* 53.3±29.1 65.2±38.3 0.154
Using internet 10.9±19.7 6.6±18.3 0.342 6.6±13.2 7.08±24.1 0.959
Playing mental games 3.4±6.4 5.7±13.5 0.430 0.0±0.0 9.3±17.6 <0.001**
*p<0.05, **p<0.001. MCI: Mild cognitive impairment.
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among diabetic males was higher compared to diabetic 
females, p > 0.05, while 2.4% of non-diabetic males 
and 13.8% of non-diabetic females had MCI with p > 
0.05. More or less similar results were reported by other 
study [20]. Mindy et al. (2017) also found that regarding 
diabetics 15.7% of diabetic males and 18.5% of diabetic 
females had MCI with p > 0.05. This difference may be 
due to that females live longer than males and a wider 
range of age of the mentioned studies [24]. The present 
study and Li et al. (2019) found that education was a 
protective factor (p < 0.01) [16].
TIIDM for more than 10 years’ duration was 
found to be significantly associated with MCI (31.1% 
of patients) compared to 7.7% among TIIDM patients 
with duration <10 years with 5 times risk of having MCI, 
p < 0.01. Several studies proved that a longer duration 
of DM has been implicated in accelerated cognitive 
decline [18], [25], [26]. History of hypoglycemic 
episodes was associated with a higher rate of MCI 
(50.0%) compared to 17.4% among those who had 
not history (OR = 4.7, 95% CI 1.4–15.5), p < 0.05. 
Similarly, other studies demonstrated that history 
of hypoglycemia was significantly associated with 
cognitive impairment [27], [28].
In addition, the present study discussed other 
risk factors for MCI among both diabetics and non-
diabetics. The rate of MCI among hypertensive diabetics 
(27.5%) and non-diabetics (20.6%) was significantly 
higher compared to non-hypertensive diabetics (9.7%) 
and non-diabetics (4.2%), p < 0.01. By making a logistic 
regression analysis, hypertension was a significant 
predicting factor for MCI among diabetics, p < 0.01. 
Among diabetics hypertensive Chen et al. (2012) denoted 
as well that the percent of hypertension among diabetics 
with MCI was 58.1% compared to 40.6% among non-
hypertensive diabetics (p < 0.05)[29]. Amer et al. (2012) 
stated that the presence of hypertension significantly 
associated with MCI (39.1%) compared to 19.4% among 
non-hypertensive with MCI patients with p < 0.05 [22]. 
The current study showed that the rate of MCI among 
diabetics and non-diabetics with history of heart 
diseases was 43.7% and 12.5%, respectively, compared 
to 17.9% and 8.3% among those with no heart problems, 
respectively, (p > 0.05). Weinstein et al. (2018) reported 
that 19.3% of diabetics with ischemic heart diseases 
had MCI compared to 11.5% among those without heart 
diseases (p < 0.001) [30]. Other studies denoted as well 
that several cardiac problems were associated with 
subsequent cognitive decline [31], [32].
Several studies evaluated the contributions of 
specific foods and nutrients to cognitive function. The 
present study showed that the mean consumption of 
the certain food items such as eggs, balanced meal, 
canned tuna, unroasted nuts, and dairy products was 
significantly higher among both diabetics and non-
diabetics with normal cognition compared to those 
with MCI. The present results were in line with Devore 
et al. (2010) and Ylilauri et al. (2017) who suggested 
that regular consumption of food such as eggs and 
nuts, could be related to more favorable cognitive 
outcomes [33], [34]. Moreover, Park and Fulgoni (2013) 
demonstrated associations between milk products and 
cheese with cognitive function [35]. Qin et al. (2014) 
supported a better role of canned tuna in slowing rate 
of cognitive decline among Chinese older adults [36].
Concerning social and mental activities among 
diabetics and non-diabetics, this study found that both 
groups with normal cognition were having more social 
activities (going to clubs, listening to the radio, and 
praying at mosques) and mental activities than those 
with MCI with p < 0.05. These were in agreement with 
other studies among TIIDM patients [37] and non-
diabetic participants [38] who denoted that among both 
groups, loneliness and social isolation significantly 
associated with a decrease in all cognitive function 
measures (p < 0.001). Choi et al. (2016) and Fu et al. 
(2018) mentioned that participation in social activities 
was significantly associated with better cognitive 
performance [39], [40]. A study in China found that there 
were statistical differences (p < 0.05) in reading, listening 
to music, and suffering the internet among the TIIDM-
MCI group and non-diabetics-MCI group [18]. Similar to 
the current study, other studies reported that increased 
participation in mental activities was associated with 
better performance on grammatical reasoning, spatial 
working memory, and episodic memory tasks [41], [42].
This study was done without funding, so it was 
carried out only on 100 diabetics and 100 non-diabetic 
participants. In the future, larger sample size studies 
are needed to confirm the results in the current study.
Conclusion
The study concluded that TIIDM is significantly 
associated with MCI and almost 3-time increasing risk 
of having MCI. Aging, hypertension, cardiovascular 
diseases, duration of disease, and frequency of 
hypoglycemic episodes are risk factors for cognitive 
impairment. A healthy diet, brain training, and social 
activities were associated with better cognitive function.
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